Krystal Biotech, Inc. (KRYS)

NASDAQ: KRYS · Real-Time Price · USD

131.60

-0.69 (-0.52%)

At close: May 20, 2025, 4:00 PM

131.55

-0.06 (-0.04%)

After-hours: May 20, 2025, 4:20 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Genetic Medicines	290.52M	Log In
Genetic Medicines Growth	473.02%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	290.52M	Log In
United States Growth	473.02%	Log In